Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03125070 · ClinicalTrials.gov registry record · Phase 3

Self-Management Program and Survivorship Care Plan in Improving the Health of Cancer Survivors After Stem Cell Transplant

A Phase 3 study, sponsored by Fred Hutchinson Cancer Center.

Completed
Registry status
Phase 3
Development phase
546
Enrollment target

NCT03125070 is a Phase 3 study that has completed, run by Fred Hutchinson Cancer Center. The registered enrollment target is 546 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03125070, a Phase 3 study, has completed, sponsored by Fred Hutchinson Cancer Center.

COMPLETED
Registry status
Phase 3
Development phase
546 participants
Enrollment target

Study Summary

This phase III trial investigates health informatics and a self-management program for improving the health of cancer survivors after stem cell transplant. After transplant many survivors may feel stressed or may be unsure of what health care they need. A self-management program called "INSPIRE," along with a personalized survivorship care plan may improve stress and health care for transplant survivors.

Interventions

  • OTHER Survey Administration
  • OTHER Best Practice and Internet site with links to existing resources
  • OTHER Internet, Mobile app and Telehealth Intervention

Trial Details

FieldValue
Enrollment Target 546 participants
Start Date 2020-10-29
Est. Completion 2023-12-31
Phase Phase 3

Sponsor

Fred Hutchinson Cancer Center

483 total trials

What the Registry Record Tells You About NCT03125070

The ClinicalTrials.gov registry entry for NCT03125070 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 546 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Fred Hutchinson Cancer Center, which has 483 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 3 interventions - of which Survey Administration is the first listed.

NCT03125070 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03125070 about?

NCT03125070 is a clinical study titled "Self-Management Program and Survivorship Care Plan in Improving the Health of Cancer Survivors After Stem Cell Transplant". This phase III trial investigates health informatics and a self-management program for improving the health of cancer survivors after stem cell transplant. After transplant many survivors may feel stressed or may be unsure of what health care they need. A self-management program called "INSPIRE," al...

What is the current status of trial NCT03125070?

This trial is currently completed. It is a Phase 3 study. The enrollment target is 546 participants. The study started on 2020-10-29. Estimated completion is 2023-12-31.

What interventions are being tested in trial NCT03125070?

The interventions under investigation include: Survey Administration (OTHER), Best Practice and Internet site with links to existing resources (OTHER), Internet, Mobile app and Telehealth Intervention (OTHER).

Who is sponsoring clinical trial NCT03125070?

This trial is sponsored by Fred Hutchinson Cancer Center, which has 483 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.